The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
November 20th 2024
While a large retrospective study found that interstitial lung abnormalities (ILAs) were evident on 1.7 percent of computed tomography (CT) scans, researchers found that 43.9 percent of ILAs, including fibrotic ILAs, were not reported.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Syncor acquires Trinidad and Tobago MRI center
April 26th 2000Syncor Overseas, a subsidiary of nuclear pharmaceutical and medical imaging company Syncor, has acquired MRI Trinidad and Tobago, an MRI center in Port of Spain, Trinidad and Tobago. Syncor acquired the center from Magnetic Resonance Imaging of Trinidad
ADAC announces new CT simulation package
April 26th 2000ADAC Laboratories, a manufacturer of nuclear medicine and radiation therapy planning systems, believes it is tapping into a new market for CT simulation products with the introduction of its SmartSim package. SmartSim is an integrated CT simulation and
CT and MRI studies expected to hit $45 million this year
March 29th 2000Nuclear cardiac perfusion studies are growing “by leaps and bounds,” according to an industry analyst, while cardiac MR and cardiac CT hover around 1% of total studies in those modalities.In 1993, cardiac perfusion studies made up only 38% of
Dedicated PET, fusion technology stimulate nuclear medicine interest
January 12th 2000Nuclear medicine firms arrived at the RSNA meeting optimistic about the modality’s potential for growth. Despite an overall flat market in 1999, vendors predict sales will climb over the next two years from $700 million to more than $1 billion,
ADAC debuts gantryless dual-head gamma camera at RSNA meeting
December 15th 1999Vendor believes Skylight could expand nuclear applications Following up on the 1998 RSNA introduction of its dual-head, open-gantry-design Forte gamma camera, ADAC Laboratories took the open gantry concept to its logical conclusion with the 1999
ADAC sees sharp 1999 net income decline
November 24th 1999Nuclear medicine vendor ADAC Laboratories reported mixed results this month when it posted its fiscal 1999 and fourth quarter (end-October) results. After more than a year of financial problems that included restating its revenues for the past three
ATL launches real-time perfusion echocardiography software
November 24th 1999Technology makes use of ultrasound contrast agents Ultrasound developers have long sought to broaden the reach of the modality to support myocardial perfusion imaging. But sonography has not yet been able to compete with nuclear medicine and
CTI, Mobile PET launch European PET unit
November 10th 1999CTI PET Systems (CPS), the joint venture between CTI and Siemens Nuclear Medicine Group, has expanded its partnership with Mobile PET Systems. The two companies announced last month the launch of a mobile PET operation that will serve European hospitals.
GE gets OK for functional anatomical mapping
October 13th 1999Only months after introducing its Functional Anatomic Mapping technology at the Society of Nuclear Medicine meeting (SCAN 6/23/99), GE Medical Systems has won clearance for the technique from the Food and Drug Administration. The technology
Schering plans purchase of peptide developer Diatide
September 29th 1999Deal continues Schering’s push into nuclear medicineThe radiopharmaceutical industry underwent some consolidation this month with the announcement that Schering AG’s management holding company, Schering Berlin, and its acquisition arm,
DOE seeks private partnerfor medical radioisotopes production
August 4th 1999Los Alamos, Sandia funding remains uncertainThe U.S. Department of Energy clarified its plans for providing medical isotopes to the U.S. nuclear medicine community at June’s Society of Nuclear Medicine meeting in Los Angeles. At the meeting,
ADAC struggles to regain footing as financial woes discourage investors
August 4th 1999Prospects strongest in PET, therapy planning, and HISNuclear medicine vendor ADAC Laboratories is enduring a tough period of business right now, particularly in its relationship with investors and the financial markets. The company no longer
Nuclear medicine market sees solid growth as PET shows signs of commercial viability
July 7th 1999Hybrid systems, expanded reimbursement take center stage at SNM meetingFor vendors at this year’s Society of Nuclear Medicine show in Los Angeles, the industry’s hard times of the mid-1990s were only a memory. While the meeting suffered
Gamma camera start-up company aims to improve scintimammography
June 23rd 1999Gamma Medica displays breast camera at SNM show Scintimammography has been slow to catch on, despite the promise of using nuclear medicine’s functional imaging ability to view the metabolism of cancerous lesions in the breast. A
GE caps rebound in nuclear medicine by grabbing spotlight at SNM meeting
June 23rd 1999Firm’s functional anatomic mapping system is highlight GE Medical Systems pulled off the corporate equivalent of a slam dunk at this month’s Society of Nuclear Medicine meeting in Los Angeles. The Milwaukee company packed crowds
New ADAC relationship prompts Hitachi to wind down nuclear medicine operations
June 23rd 1999Technology may find a new home at other companies, however Japanese multimodality vendor Hitachi Medical has decided to put an end to the sale and marketing of its own gamma cameras, the company disclosed at this month’s Society of
ADM forms partnership with ADAC to launch nuclear services venture
June 23rd 1999FirstNuclear includes both equipment and service Imaging services provider American Diagnostic Medicine (ADM) launched a joint venture with ADAC Laboratories this month designed to make it easier for hospitals to begin offering nuclear
Siemens tackles budget niche with new single-head E.Cam camera
May 26th 1999New version slated for low-cost single-head marketWith more than 600 of its variable-angle E.Cam gamma cameras installed worldwide, the nuclear medicine group of Siemens Medical Systems continues the robust recovery that began with the debut of
SMV to highlight SPECT features for high-energy imaging at SNM show
May 26th 1999Company emphasizes crystal, long-access optionsNuclear medicine vendor SMV America plans to roll into the Society of Nuclear Medicine show next month in Los Angeles with a broad range of coincidence detection options and upgrades for its gamma
Toshiba to stress efficiency at SNM show
May 26th 1999Toshiba America Medical Systems plans to emphasize productivity gains, as well as its coincidence-ready E.Cams with 5/8-inch crystals, at next month's Society of Nuclear Medicine show in Los Angeles. The Tustin, CA, company received clearance for
GE to debut new mini cyclotron
May 26th 1999GE Medical Systems will introduce a new cyclotron at next month’s Society of Nuclear Medicine meeting in Los Angeles that is targeted to produce radiopharmaceuticals for individual PET sites. The new cyclotron is called MINItrace and is a smaller
ADAC to highlight new cardiac camera
May 26th 1999Nuclear medicine developer ADAC Laboratories of Milpitas, CA, will introduce a new version of its dedicated cardiac gamma camera at next month’s Society of Nuclear Medicine meeting in Los Angeles. ADAC has taken the basic design of its Cardio
ADAC postpones release of Q2 numbers
May 26th 1999Nuclear medicine vendor ADAC Laboratories continues to be plagued by accounting snafus. The Milpitas, CA, company announced May 19 that it will delay the release of its financial results for the second quarter (end-April) as it evaluates whether
Hitachi halts R&D for new gamma cameras after signing distribution deal with ADAC
May 12th 1999Company will sell and support existing nuclear medicine systemsHitachi Medical’s nascent drive to become a nuclear medicine powerhouse appears to have come to an end. The Tokyo company has decided to discontinue development and manufacturing
ADAC warns of lower Q2 results
April 28th 1999Nuclear medicine developer ADAC Laboratories issued a warning to the financial markets on April 21, stating that the Milpitas, CA, company expects to post lower than anticipated profits and revenues for the second quarter (end-April). ADAC believes that
ADAC issues restated financial numbers
March 17th 1999Nuclear medicine vendor ADAC Laboratories of Milpitas, CA, this month issued restated financial results for the years 1996 through 1999 (see chart). At the same time, the company released financial results for the first quarter of 1999 (end-January) that
Attempt to broaden PET Medicare payments receives cool reception from HCFA officials
February 17th 1999Sen. Stevens may step in again if reimbursement does not materializeIt may take some effort for the nuclear medicine community to increase the number of PET applications eligible for Medicare reimbursement. At a town hall meeting in Baltimore last